Dopaminergic systems in the brain adapt in response to a variety of stimuli from the internal and external world, but the mechanisms underlying this process are incompletely understood. In recent years, evidence has emerged that certain types of transcription factor of the nuclear receptor family, specifically Nur77 and retinoid X receptors, play an important role in the Nuradaptation, and importantly, in the homeostatic regulation, of dopaminergic systems. These findings call for a reassessment of our fundamental understanding of the molecular and cellular basis of dopaminergic transmission. Given that diseases such as Parkinson's disease and schizophrenia are thought to involve maladaptation of dopamine signalling, these findings might lead new insight into these pathologies and offer new avenues for drug development.